Analystreport

Oyster Point Pharma (NASDAQ: OYST) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating.

Oyster Point Pharma, Inc. - common stock  (OYST) 
Last oyster point pharma, inc. - common stock earnings: 2/27 04:01 pm Check Earnings Report